<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Pelvic inflammatory disease (PID) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Pelvic inflammatory disease (PID)</h1>
        <div class="sub">PID: recognise (low threshold), exclude pregnancy/surgical emergency, treat empirically, arrange 72h review, and know when to admit / refer.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑09</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points</strong>
                <ul>
                  <li>Clinical diagnosis is <strong>imprecise</strong>; guidance supports a <strong>low threshold</strong> for empiric treatment once pregnancy is excluded, because delaying therapy increases risk of infertility, ectopic pregnancy and chronic pelvic pain.</li>
                  <li>Typical symptoms/signs: <strong>recent onset bilateral lower abdominal pain</strong> + <strong>cervical motion tenderness/adnexal tenderness</strong> ± abnormal bleeding, discharge, dyspareunia, fever.</li>
                  <li>Test for <strong>chlamydia + gonorrhoea</strong> (and ideally <strong>M. genitalium</strong> if available) but <strong>negative tests do not exclude PID</strong>.</li>
                  <li>Baseline actions in primary care: <strong>pregnancy test</strong>, assess for <strong>surgical emergency</strong>, start antibiotics, advise no unprotected sex until completion, and arrange <strong>review at 72 hours</strong> (earlier if worsening).</li>
                  <li>Consider admission/IV antibiotics for <strong>severe disease</strong> (e.g. fever &gt;38°C, peritonism, suspected tubo-ovarian abscess), <strong>pregnancy</strong>, <strong>diagnostic uncertainty</strong> (cannot exclude appendicitis/ectopic/ovarian torsion), or <strong>no improvement</strong> after oral therapy.</li>
                  <li>Partner management matters: current partner(s) should be contacted for testing, and many pathways recommend empiric cover for male partners (e.g. doxycycline) alongside sexual health follow-up.</li>
                </ul>
              </div>

              <div class="callout warn">
                <strong>Local (D&amp;G): routing assumptions to confirm</strong>
                <ul>
                  <li>Default route for <strong>PID follow-up + partner notification</strong>: local <strong>sexual health/GUM</strong> service vs GP-led.</li>
                  <li>Where to refer <strong>suspected tubo-ovarian abscess</strong> (acute gynae vs general surgery vs ED pathway).</li>
                  <li>Whether D&amp;G wants any <strong>routine gynae</strong> referrals for persistent symptoms after treated PID (vs pelvic pain/endometriosis pathway).</li>
                </ul>
              </div>

              <h4>Comparator sources used for the draft</h4>
              <ul>
                <li>BASHH (2019 interim update): UK national guideline summary + recommended outpatient/inpatient regimens + follow-up.</li>
                <li>Right Decisions (NHS Scotland) PID guideline PDF (service-model comparator; helpful for admission triggers and practical wording).</li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">
            <div id="draftText" class="section">
              <h3>Pelvic inflammatory disease (PID) (primary care)</h3>

              <h4>Background</h4>
              <ul>
                <li>PID = ascending infection from cervix → endometritis/salpingitis ± tubo-ovarian abscess/peritonitis.</li>
                <li>Common pathogens: <strong>chlamydia</strong>, <strong>gonorrhoea</strong>; mixed vaginal flora/anaerobes; <strong>M. genitalium</strong> can be a cause.</li>
                <li>Key principle: if suspicion is reasonable and pregnancy excluded, <strong>treat empirically</strong> (do not wait for swab results).</li>
              </ul>

              <h4>Red flags / same-day assessment</h4>
              <ul>
                <li><strong>Possible ectopic pregnancy</strong> (missed period/positive test, unilateral pain, collapse, shoulder tip pain) → urgent assessment.</li>
                <li><strong>Surgical abdomen / diagnostic uncertainty</strong> (appendicitis, ovarian torsion/rupture) → ED / surgical &amp; gynae assessment.</li>
                <li><strong>Severe clinical disease</strong>: fever &gt;38°C, peritonism, severe pain/vomiting, systemic unwell, suspected pelvic peritonitis.</li>
                <li><strong>Suspected tubo-ovarian abscess</strong> (marked tenderness, pelvic mass, very unwell) → admit/urgent imaging.</li>
                <li><strong>Pregnancy</strong> (PID uncommon but higher maternal/fetal risk) → same-day specialist assessment; parenteral therapy usually advised.</li>
                <li><strong>Unable to tolerate oral antibiotics</strong> or concern re adherence/safeguarding → consider admission.</li>
              </ul>

              <h4>Assessment (primary care)</h4>
              <ul>
                <li><strong>History:</strong> onset/duration; bilateral lower abdominal pain; dyspareunia; abnormal bleeding (IMB/PCB/menorrhagia); discharge; fever; vomiting; pregnancy risk; IUD insertion in last 4–6 weeks; STI risk.</li>
                <li><strong>Examination:</strong> abdominal tenderness/peritonism; speculum (discharge, cervicitis); bimanual (cervical motion tenderness/adnexal tenderness); consider pelvic mass.</li>
                <li><strong>Tests:</strong>
                  <ul>
                    <li><strong>Pregnancy test</strong> (do first).</li>
                    <li><strong>NAAT</strong> for chlamydia/gonorrhoea; add <strong>M. genitalium</strong> if available locally.</li>
                    <li>Consider HIV/syphilis testing as per sexual health pathways.</li>
                    <li>CRP/ESR may support diagnosis but are non-specific; use clinically.</li>
                  </ul>
                </li>
              </ul>

              <h4>Primary care management (uncomplicated / mild–moderate)</h4>
              <ul>
                <li><strong>Start antibiotics immediately</strong> once pregnancy excluded and suspicion is reasonable.</li>
                <li><strong>Analgesia</strong>; rest if severe symptoms.</li>
                <li><strong>Sex:</strong> avoid unprotected sex until patient and partner(s) have completed treatment and follow-up.</li>
                <li><strong>Safety-net:</strong> return urgently if worsening pain, fever, vomiting, faint/collapse, new peritonism.</li>
              </ul>

              <h4>Suggested antibiotic regimen (check local antimicrobial guidance)</h4>
              <ul>
                <li><strong>First-line outpatient (BASHH):</strong> IM ceftriaxone 1 g stat <strong>plus</strong> doxycycline 100 mg BD 14 days <strong>plus</strong> metronidazole 400 mg BD 14 days.</li>
                <li><strong>Alternatives</strong> exist (including quinolones/moxifloxacin) but are usually <strong>second line</strong> due to resistance and serious adverse-effect warnings; use local guidance / sexual health advice.</li>
                <li><strong>If M. genitalium positive</strong>, BASHH recommends moxifloxacin (specialist/sexual health input advised).</li>
              </ul>

              <h4>Review and follow-up</h4>
              <ul>
                <li><strong>Review at 72 hours</strong> (earlier if moderate/severe symptoms). If no improvement → consider admission, imaging, and/or alternative diagnosis; switch to parenteral therapy where appropriate.</li>
                <li>Consider review at <strong>2–4 weeks</strong> to confirm symptom resolution, adherence, partner management completed, and to re-test if indicated.</li>
              </ul>

              <h4>Who to refer / admit</h4>
              <ul>
                <li><strong>Same day / admit:</strong> severe disease, pregnancy, suspected tubo-ovarian abscess, cannot exclude surgical emergency, inability to tolerate oral therapy, or no improvement at 72 hours.</li>
                <li><strong>Sexual health/GUM:</strong> for partner notification, STI testing/treatment, and where available M. genitalium testing and management.</li>
                <li><strong>Routine gynae:</strong> persistent pelvic symptoms after treated PID where alternative pathology suspected (e.g. endometriosis, chronic pelvic pain) — local pathway decision.</li>
              </ul>

              <h4>Who not to refer (usually)</h4>
              <ul>
                <li>Clinically improving uncomplicated PID managed as outpatient, with arranged 72h review and sexual health follow-up/partner management.</li>
              </ul>

              <h4>Referral letter / triage metrics (if referring)</h4>
              <ul>
                <li>Pregnancy test result and LMP.</li>
                <li>Symptoms: onset, severity, fever/vomiting, bleeding/discharge, dyspareunia.</li>
                <li>Exam: peritonism? cervical motion tenderness? adnexal tenderness/mass?</li>
                <li>Swabs: chlamydia/gonorrhoea (and M. genitalium if done) — date + results if available.</li>
                <li>Treatment started: antibiotics + start date/time; response at 72h if known.</li>
                <li>IUD in situ? inserted within last 4–6 weeks?</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed (D&amp;G)</strong>
                <ul>
                  <li>[ ] Confirm local outpatient antibiotic regimen (align with D&amp;G antimicrobial policy; dose/formulary differences).</li>
                  <li>[ ] Confirm default service for PID follow-up + partner notification (Sexual Health vs GP).</li>
                  <li>[ ] Confirm admission route for suspected tubo-ovarian abscess (ED → gynae?) and whether urgent ultrasound is via A&amp;E/SAS/acute gynae.</li>
                  <li>[ ] Confirm whether any groups should be referred directly to gynae when stable (e.g. recurrent PID, persistent symptoms after 2–4 weeks, IUD-related cases).</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ul>
                <li>BASHH. <em>United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (PID) – 2019 interim update</em> (web summary + PDF). Last updated 26 Jan 2019. Accessed 2026‑02‑09. https://www.bashh.org/resources/6/pid_2019/</li>
                <li>Right Decisions (NHS Scotland). <em>Pelvic inflammatory disease (PID): diagnosis and management</em> (PDF). Accessed 2026‑02‑09. https://www.rightdecisions.scot.nhs.uk/media/ms5nxbos/pelvic-inflammatory-disease-diagnosis-and-management-v5-504.pdf</li>
              </ul>
              <p class="small">Draft note: antibiotic regimens must be checked against local antimicrobial guidance; BASHH dosing shown for drafting/structure.</p>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
